RetractedTrialBioMed research international2022

Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.

Wenbin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.